Log In
BCIQ
Print this Print this
 

TORKi (CC-223)

  Manage Alerts
Collapse Summary General Information
Company Celgene Corp.
DescriptionMammalian target of rapamycin (mTOR; FRAP; RAFT1) kinase inhibitor
Molecular Target Mammalian target of rapamycin (mTOR) (FRAP) (RAFT1)
Mechanism of ActionMammalian target of rapamycin (mTOR) kinase inhibitor
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today